Therefore, ATR mutations can promote endometrial cancer tumorigenesis in the context of MSI, which may be related to tumor invasiveness, and identifying ATR mutation status is helpful for targeted therapy of endometrial cancer. The gene discussed is ATR; the disease is neoplasm.